A phase II, open-label, uncontrolled, single center study to evaluate safety and immunogenicity of a surface antigen, inactivated influenza vaccine Ph.Eur, formulation 2007-2008, when administered to non-elderly adult and elderly subjects.

Trial Profile

A phase II, open-label, uncontrolled, single center study to evaluate safety and immunogenicity of a surface antigen, inactivated influenza vaccine Ph.Eur, formulation 2007-2008, when administered to non-elderly adult and elderly subjects.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 29 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top